Background: Sinonasal symptoms are common and can have several underlying
| INTRODUCTION
Chronic rhinosinusitis (CRS) is an inflammatory condition characterized by sinonasal symptoms, affecting up to 15% of the US population. 1 Various groups have defined 4 cardinal symptoms of the disease which include nasal blockage/congestion, drainage (anterior or posterior combined into single question), smell loss, and facial pain or pressure (combined into single question) lasting at least 12 weeks. [2] [3] [4] [5] The European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS) has outlined criteria for clinical diagnosis of CRS, requiring subjective symptoms (nasal obstruction or discharge and at least one other symptom) lasting 3 months and objective evidence of inflammation on sinus computerized tomography (CT) scan or endoscopy. 1 Obtaining sinus CT or endoscopy in large-scale population studies is a recognized challenge; therefore, EPOS also advances an epidemiologic definition of CRS based on the presence and duration of symptoms only (which we term EPOS s CRS, as the definition relying on subjective symptoms). However, EPOS does not specify how to measure symptoms in terms of severity (eg, partial or complete blockage or smell loss and quantity of discharge) or frequency (eg, some, most, or all of the time) during the required 3-month duration.
Current guidelines for CRS primarily divide CRS into one of two primary phenotypes, based on the presence or absence of nasal polyps. However, increasing evidence reveals that CRS is likely much more heterogeneous, with endotypes that are defined by distinct pathophysiologic mechanisms that can be characterized by differences in responses to different treatment options. 6 These endotypes may present with heterogeneous patterns of sinonasal symptoms that could be used in clinical settings to inform targeted treatment strategies. However, to date, the ways in which sinonasal and related symptoms co-occur remain relatively unexplored. [7] [8] [9] Incorporating a large, prospective longitudinal cohort of subjects from Geisinger, an integrated health system, we used exploratory factor analysis (EFA) to assess the existence and structure of latent constructs (as yet unidentified subject attributes driving manifestation of symptoms) of sinonasal and other relevant symptoms.
Exploratory factor analyses was applied to symptoms at 3 separate time points over 16 months and the change in symptoms between time points. Prior studies have used EFA applied to CRS symptoms at one point in time, but utilized the Sino-nasal Outcome Test (SNOT) family of questionnaires, designed to assess treatment effectiveness among subjects known to have CRS. 2, 10, 11 SNOT assesses symptom severity only in a 2-week recall window, so it cannot be used to evaluate compliance with EPOS duration criteria and does not evaluate symptom frequency. 1, 11 The questionnaire utilized in this study assessed frequency, bother, and severity of cardinal EPOS symptoms and related and comorbid symptoms (eg, ear, eye, allergy, asthma, headache, fatigue, cold, and flu), to assess a broad range of manifestations potentially associated with sinonasal disease. Understanding how symptoms group together and change over time may allow development of more precise approaches to symptom measurement and help identify biologic rationales for clustered symptoms. To our knowledge, this is the first use of EFA applied to longitudinal information on a broad range of symptoms relevant to sinonasal disease in a sample representative of the general population. 
| METHODS

| Study population and design
| Data collection
The questionnaires included items on the presence, frequency, severity, and bother of a range of symptoms associated with sinonasal disease and comorbid conditions (Table S1) . [12] [13] [14] Each questionnaire included 37 questions in common with the same response options (how often the symptom occurred in the past 3 months as 1 = never, 2 = once in a while, 3 = some of the time, 4 = most of the time, or 5 = all the time; Table S1 ). A total of 21 questions were about the presence, severity, and degree of bother of sinonasal symptoms, while the remaining questions assessed the presence of 4 asthma symptoms, 4 allergy symptoms, 3 ear symptoms, and 5 cold/ flu symptoms and other related symptoms (Table S1 ).
Highlights
• Exploratory factor analysis of 37 symptom questions from three questionnaires obtained from 3535 subjects over 16 months consistently identified five symptom factors.
• The five symptom factors-blockage and discharge, pain and pressure, asthma and cold/flu symptoms, smell loss, and ear and eye (mainly allergy) symptoms-were present in cross-sectional and longitudinal analyses.
• The findings suggest that current approaches to symptom measurement in CRS should be reconsidered, and frequency and severity of symptoms should be incorporated.
| Analytic variables
EPOS s criteria were used to classify subjects as current, past, or never CRS based on self-reported current and past symptoms from the baseline questionnaire as previously reported. 13 The questionnaire has been previously described 13 and included sociodemographic items at baseline. Health information such as body mass index (BMI, measured in kg/m 2 ) was derived from EHR data and linked to questionnaire data.
| Statistical analysis
| Overview
The goals of the analysis were to identify the latent constructs and their underlying structure, if present, among the 37 questions at each questionnaire time point and then among the change in these symptoms over time from adjacent questionnaires (ie, baseline to 6-month and 6-month to 16-month 
| Exploratory factor analysis
Subjects included in the analysis were first compared to subjects not included on demographic, health, and socioeconomic variables to evaluate selection bias. Exploratory factor analyses was next utilized to evaluate the latent constructs and underlying structure of symptom reporting because there were multiple hypotheses and little a priori knowledge of how symptoms might cluster. Implied Pearson's (polychoric) correlations were estimated among the 37 questions for the 3 cross-sectional questionnaires, using the 2-step procedure as implemented by the psych R package. 16 These correlations were then utilized in the EFAs. Pearson's correlation matrices were calculated for each of the 2 change scores as the difference score distribution appeared symmetric and contained more values than practical for polychoric correlations.
| Factor scores and communalities
Each of the 5 EFAs was conducted fitting loadings, estimates, and communalities applying the ordinary (unweighted) least squares (OLS/ULS) procedure to correlations estimated as previously described. We used an oblimin rotation for each EFA to allow factors to be correlated. 16 The number of factors to extract was determined through Cattell's scree test and parallel analysis. 17, 18 Factor loadings (values generally ranging from À1 to 1) provide a measure of the strength of the relationship between each question and each of the extracted factors, while the communalities for each question, which range from 0 to 1, are interpreted as the fraction of each question's variability that is explained by the factor model.
Once factor loadings were extracted, item response theory (IRT) scores were estimated for each identified factor for each subject using the polytomous items from each of the questionnaires. 19 These estimated scores were computed as a measure of the strength of each latent factor for each subject. A factor score correlation matrix was first examined to evaluate correlations among the 5 factors. Lasagna plots were examined to visually assess the changes in quintiles of factor scores over time. 20 We next evaluated factor scores by EPOS s CRS status groups factor score and higher scores, respectively. Finally, we evaluated whether the first factor change score, over 6 months, captured more variability in symptoms than the second change score, over 10 months, by comparing EFA communalities using a Wilcoxon signed rank test. We hypothesized that models would explain more variation in symptoms and thus have higher mean communality values, for the first change score because of the shorter duration for change.
| Diagnostics and sensitivity analysis
Extensive diagnostics and sensitivity analyses were completed to confirm the fit and adequacy of EFA models and the sensitivity of results to factoring method and imputation (described in Data S1).
| RESULTS
| Description of study subjects
The 3535 subjects included in the analysis were first compared to the 4312 respondents from the baseline questionnaire excluded from analysis ( Across questionnaires, it was common for symptoms to change by one frequency category, with relatively few subjects changing by 2 or more (eg, results for blockage frequency in Figure 1 ). For blockage frequency, the majority of those who answered "never" having blockage in the previous 3 months at baseline also reported infrequent blockage at follow-up. Similar patterns of change were observed among subjects who were in other categories of blockage frequency reporting at baseline. This overall pattern of symptom reporting across questionnaires was evident for other symptom questions as well (results not shown).
| Cross-sectional EFAs
For EFAs were similar: one factor each for symptoms of blockage and discharge, pain and pressure (including headache), asthma and cold/ flu symptoms, ear and eye, and smell loss (Table 2 for baseline EFA, other 2 cross-sectional EFAs in Tables S2 and S3 ). Factor loadings (the degree to which specific question was related to latent factor)
were consistent across all questionnaires (Tables 2 and S2 and S3) .
Most observed communalities were high, indicating that the factor models well-represented questions included in the analysis (Tables 2   and S2 
| Longitudinal difference EFAs
The 2 longitudinal difference EFAs also supported 5 factor models (scree plots in Figures S4 and S5) . Symptoms identified to load on single factors in the difference analyses indicated that these symptoms changed together and in the same direction over time. Notably, both difference EFAs yielded nearly identical factors and structures ( Tables 3 and S4) to the cross-sectional EFAs. As expected, given the shorter duration for change, the baseline to 6-month difference EFA had a significantly greater average communality than did the 6-month to 16-month difference EFA (P-value = .002 from Wilcoxon signed rank test; Table S5 ).
| Factor scores
Using the baseline model to estimate factor scores within individuals at baseline, correlations among the 5 factor scores ranged from 0.30 to 0.64. The highest interfactor correlations were observed between T A B L E 2 Factor loadings and symptom communalities from the exploratory factor analysis (EFA) a of 37 questions about the presence, frequency, and severity of sinonasal and related symptoms on the baseline questionnaire from 3535 subjects The EFA was fit using ordinary least squares(OLS) and an oblimin rotation. Loadings less than 0.3 were omitted for readability. Communalities represent the fraction of each symptom's variability that was captured by the utilized 5 factor models.
the blockage and discharge factor with the pain and pressure factor (q = .64) and the smell loss factor (q = .61; Figure S6 ). There was a significant difference (P-value <.001) in mean factor scores for factors 1, 2, 3, and 5 between EPOS s CRS groups (current, past, and never; Figure 2 for factor 1). We observed factor scores were higher, in descending order, for current, past, then never CRS groups.
Examination of factor scores across questionnaires (categorized values in Figure 3 for factor 1) showed that there was change in factor scores over time. Logistic and linear regression models revealed that EPOS s CRS status was positively associated with smell loss (factor 4)
scores. Current and past EPOS s CRS at baseline (vs never) were associated with a much lower odds of having low factor scores (odds T A B L E 3 Factor loadings and symptom communalities from the exploratory factor analysis (EFA) a of change in responses from the 6-to 16-month questionnaire on 37 questions about the presence, frequency, and severity of sinonasal and related symptoms from 3535 subjects 
| DISCUSSION
Exploratory factor analyses was used to better understand the existence and structure of latent constructs underlying symptoms which have been traditionally categorized as major and minor CRS symptoms 21 as well as symptoms associated with CRS comorbidities.
Notably, this was performed in a general population representative sample utilizing both cross-sectional symptom questionnaires and changes in symptom responses over time. The analysis of sinonasal, asthma, headache, cold/flu, allergy, and ear symptoms identified 5 factors (ie, symptom clusters representing latent constructs) that were similar in all 3 cross-sectional and 2 difference analyses, despite some change in symptoms over time. The 5 factors were blockage and discharge, pain and pressure, asthma and cold/flu, smell loss, and ear and eye symptoms (mainly allergy). All 5 factor scores were highest in subjects who met EPOS s current CRS criteria and lowest in those who met EPOS s never CRS criteria. Understanding how symptoms cluster within and across questionnaires can provide useful information that can aid clinical practice, inform symptom measurement in CRS, and lead to hypotheses about the pathobiology underlying these clusters.
In EPOS guidelines, the 6 symptoms we measured are reduced to 4 as anterior and posterior discharge and pain and pressure are combined. European Position Paper on Rhinosinusitis and Nasal Polyps considers these 4 cardinal symptoms to be mainly interchangeable, with one required symptom (one of the 3 blockage or discharge symptoms) and one other symptom to meet EPOS criteria.
If there was an underlying construct of CRS that could be measured with the cardinal symptoms, the EPOS criteria suggest symptoms should only load on 1 or 2 factors. We subjected a larger group of 37 symptom questions, encompassing common sinonasal and comorbid condition symptoms, and expanded to evaluate how severity, bother, or frequency influenced clustering. The results suggested that frequency, severity, and bother were all important to clustering of symptoms within factors. European Position Paper on Rhinosinusitis and Nasal Polyps allows either blockage or discharge to be a separate required symptom, but we found that all 12 blockage and discharge questions loaded on a single factor, suggesting these symptoms do not occur independently of one another. We found that the 37 symptoms identified 5 factors and the 6 EPOS CRS symptoms clustered in 3 factors (ie, nasal blockage and discharge, F I G U R E 2 Factor 1 (blockage and discharge) scores by EPOS s chronic rhinosinusitis (CRS) groups (current, past, and never) at baseline. The number of subjects in each group is indicated. Factor scores were estimated by the item response theory (IRT) method. The X-axis was jittered to improve readability F I G U R E 3 Continuous factor scores categorized to show longitudinal change across questionnaires for factor 1 (blockage and discharge). Factor scores were categorized as: factor score <À0. 4 were assigned values of À1; between À0.4 and 0.6, assigned 0; between 0.6 and 1. There has been increasing recognition of the heterogeneity of CRS with a focus on multiple groups of endotypes. 6, 25 An important question is whether the clustering of symptoms we observed represents one or more endotypes with distinct underlying pathobiologic processes or anatomic relationships. In a prior study, we found that similar distinct sinonasal symptom patterns within individuals meeting EPOS s differed by age, sex, selected risk factors, and health outcomes, providing some evidence that CRS symptom subgroups may represent distinct disease processes. 13 The ability to use symptoms to identify subtypes of CRS that might differ by inflammatory processes, location of sinus opacification, and comorbidities, for example, has important implications for targeted treatment of the disease.
The consistency of the 5 factors in all 5 EFA models, despite the presence of some longitudinal change in symptoms, also provides some evidence that these 5 factors may each have an underlying pathobiology. EFA theory hypothesizes that there are real underlying mechanisms, including common pathobiology or reporting phenomena, which manifests in clustering of symptoms into observed factors. If this hypothesis was correct, we would expect factor composition to be invariant to time (ie, within questionnaires and no seasonality) and to see symptoms cluster over time according to these same factors. Our observed results supported both of these expectations.
Analysis of multidimensional mean factor scores showed that EPOS s current CRS had the highest factor scores, followed by the past CRS group (P-values <.01). This result is unsurprising as the CRS groups here were determined by the EPOS s definition, which itself is based on many of the symptoms in the factors; however, the EFA included many questions beyond those used to define EPOS s CRS status. The factor scores comprised of eye, ear, asthma, cold/ flu, and headache symptoms may represent the common co-occurrence of allergy, asthma, and headache disorders, for example, among patients with sinonasal disease.
While there has been some prior work on CRS symptom factors at a single point in time with the SNOT-20 and SNOT-22 questionnaires, prior work on factors using longitudinal information on symptoms has generally focused on the impact of treatment. 10, 26 The SNOT questionnaires using 20 or 22 Likert-scale questions ask the participants to consider physical, functional, and emotional symptoms in the previous 2 weeks. 27, 28 SNOT was designed to provide a single measure of patient quality of life and CRS-related symptom severity and implicitly suggesting that the combined questions provide information regarding a single CRS construct or factor. 10 We observed differences between subjects included and excluded from the analysis. Included subjects were more likely to be white, more highly educated, and have higher incomes. This may have resulted in selection bias that could have influenced the results.
In addition, there is the potential of same source bias impacting results by which some individuals report in a systemic manner (eg, always or never reporting symptoms, or more likely to report symptoms located near each other on the questionnaire with the same response item). Finally, while we found strong evidence of clustering among 37 symptoms within visits and over time, the ultimate utility of the findings will be in whether these 5 factors identify unique CRS subgroups (new approaches to phenotypes, or combined with molecular measurements into endotypes) that predict natural history, response to treatment, or long-term outcomes.
| CONCLUSION S
In an analysis of 37 sinonasal, allergy, ear, asthma, headache, and cold/flu symptoms, we identified 5 underlying factors-blockage and discharge, pain and pressure, asthma and cold/flu, ear and eye, and smell loss-that were very consistent in 3 cross-sectional and 2 longitudinal change EFAs. Questions assessed the presence, severity, bother, and frequency of all 37 symptoms. Frequency, severity, and degree of bother were each important to clustering of symptoms within factors, and this clustering within factors was stable over time. The findings have implications for how to measure sinonasal symptoms in epidemiologic studies of CRS and possibly in the clinical setting too (eg, EPOS criteria). Future consideration should be given to whether and how to incorporate frequency and severity into symptom measurement to optimize diagnosis and care for patients with nasal and sinus symptoms.
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